Bioinformatics Analysis and Validation Identify CDK1 and MAD2L1 as Prognostic Markers of Rhabdomyosarcoma.

Suying LuChengtao SunHuimou ChenChao ZhangWei LiLiuhong WuJia Zhu Feifei Sun Junting HuangJuan WangZijun ZhenRuiqing CaiXiaofei SunYizhuo ZhangXing Zhang

Published in: Cancer management and research (2020)

This study has identified that CDK1 and MAD2L1 were adverse prognostic factors of RMS.

Keyphrases

prognostic factors
bioinformatics analysis
cell cycle
emergency department
cell proliferation
adverse drug